Publicacións nas que colabora con Antonio Piñeiro Ces (23)

2023

  1. PARK7/DJ-1 inhibition decreases invasion and proliferation of uveal melanoma cells

    Tumori, Vol. 109, Núm. 1, pp. 47-53

2022

  1. Applications of Non-Coding RNAs in Patients With Retinoblastoma

    Frontiers in Genetics, Vol. 13

  2. Identificación de extensión extraocular en el melanoma uveal mediante ecografía oftalmológica

    Archivos de la Sociedad Española de Oftalmologia, Vol. 97, Núm. 2, pp. 70-76

  3. Noncoding RNAs in intraocular tumor patients

    Clinical Applications of Noncoding RNAs in Cancer (Elsevier), pp. 177-210

2021

  1. Role of somatic mutations and chromosomal aberrations in the prognosis of uveal melanoma in a Spanish patient cohort

    Acta Ophthalmologica, Vol. 99, Núm. 7, pp. e1077-e1089

2020

  1. Intercellular trafficking of gold nanostars in uveal melanoma cells for plasmonic photothermal therapy

    Nanomaterials, Vol. 10, Núm. 3

  2. The role of non-coding RNAs in uveal melanoma

    Cancers, Vol. 12, Núm. 10, pp. 1-22

  3. Treatment of metastatic uveal melanoma: Systematic review

    Cancers, Vol. 12, Núm. 9, pp. 1-22

2018

  1. Melanoma uveal: Braquiterapia

    Annals d'oftalmologia: òrgan de les Societats d'Oftalmologia de Catalunya, Valencia i Balears, Vol. 26, Núm. 3

2017

  1. In Vitro Evaluation of the Ophthalmic Toxicity Profile of Chlorhexidine and Propamidine Isethionate Eye Drops

    Journal of Ocular Pharmacology and Therapeutics, Vol. 33, Núm. 3, pp. 202-209

2016

  1. Evaluation of the in vitro ocular toxicity of the fortified antibiotic eye drops prepared at the hospital pharmacy departments

    Farmacia Hospitalaria, Vol. 40, Núm. 5, pp. 352-370

2015

  1. Detection of circulating melanoma cells in choroidal melanocytic lesions Cancer

    BMC Research Notes, Vol. 8, Núm. 1

  2. ME20-S as a potential biomarker for the evaluation of uveal melanoma

    Investigative Ophthalmology and Visual Science, Vol. 56, Núm. 12, pp. 7007-7011

  3. Ocular safety comparison of non-steroidal anti-inflammatory eye drops used in pseudophakic cystoid macular edema prevention

    International Journal of Pharmaceutics, Vol. 495, Núm. 2, pp. 680-691

  4. Serum dipeptidyl peptidase IV activity and sCD26 concentration in patients with choroidal nevus or uveal melanoma

    Clinica Chimica Acta

2014

  1. Detecting ultrasonographic hollowness in small choroidal melanocytic tumors using 10 MHz and 20 MHz ultrasonography: a comparative study

    Graefe's Archive for Clinical and Experimental Ophthalmology, Vol. 252, Núm. 12, pp. 2005-2011

2012

  1. Diseño de una base de datos informatizada para la gestión clínica y básica del melanoma uveal

    Archivos de la Sociedad Española de Oftalmologia, Vol. 87, Núm. 9, pp. 278-283

  2. Serum DJ-1/PARK 7 is a potential biomarker of choroidal nevi transformation

    Investigative Ophthalmology and Visual Science, Vol. 53, Núm. 1, pp. 62-67

2006

  1. The characterization of the invasion phenotype of uveal melanoma tumour cells shows the presence of MUC18 and HMG-1 metastasis markers and leads to the identification of DJ-1 as a potential serum biomarker

    International Journal of Cancer, Vol. 119, Núm. 5, pp. 1014-1022

2005

  1. Proteome analysis of a human uveal melanoma primary cell culture by 2-DE and MS

    Proteomics, Vol. 5, Núm. 18, pp. 4980-4993